SAN CARLOS, Calif. — Cerepeut, Inc., a biotechnology company developing mitochondrial therapeutics for neurodegenerative disease, today announced publication of a landmark study in Neuron revealing why the brain turns on itself in Alzheimer’s disease and related disorders, and unveiling a drug candidate designed to stop it. Tau is a well-known driver...

AUSTIN, Texas and NEW YORK, NY — The Foundation for Angelman Syndrome Therapeutics (FAST), the leading patient advocacy organization working to support the development of transformative treatment options for Angelman syndrome, today announced that it has entered into an agreement with Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for...

London, UK – Researchers in Europe have identified two highly sensitive lung tests that can detect subtle worsening of cystic fibrosis (CF) lung disease—even when conventional breathing tests suggest patients are stable. The findings indicate that oxygen-enhanced MRI (OE-MRI) and multiple breath washout with Short extension (MBWShX) may provide a...